South Korea · Delayed Price · Currency is KRW TegoScience Statistics
Total Valuation
TegoScience has a market cap or net worth of KRW 60.69 billion. The enterprise value is 33.48 billion.
| Market Cap | 60.69B |
| Enterprise Value | 33.48B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TegoScience has 8.01 million shares outstanding. The number of shares has increased by 0.40% in one year.
| Current Share Class | 8.01M |
| Shares Outstanding | 8.01M |
| Shares Change (YoY) | +0.40% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 42.32% |
| Owned by Institutions (%) | 0.14% |
| Float | 4.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.82 |
| PB Ratio | 1.39 |
| P/TBV Ratio | 1.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 5.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.65, with a Debt / Equity ratio of 0.42.
| Current Ratio | 1.65 |
| Quick Ratio | 1.55 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.07 |
| Interest Coverage | -2.85 |
Financial Efficiency
Return on equity (ROE) is -25.29% and return on invested capital (ROIC) is -36.56%.
| Return on Equity (ROE) | -25.29% |
| Return on Assets (ROA) | -4.79% |
| Return on Invested Capital (ROIC) | -36.56% |
| Return on Capital Employed (ROCE) | -13.86% |
| Weighted Average Cost of Capital (WACC) | 8.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.08 |
| Inventory Turnover | 0.89 |
Taxes
| Income Tax | -2.22B |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -58.29% in the last 52 weeks. The beta is 0.67, so TegoScience's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -58.29% |
| 50-Day Moving Average | 6,959.20 |
| 200-Day Moving Average | 11,740.40 |
| Relative Strength Index (RSI) | 53.44 |
| Average Volume (20 Days) | 5,131 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TegoScience had revenue of KRW 6.18 billion and -12.91 billion in losses. Loss per share was -1,611.49.
| Revenue | 6.18B |
| Gross Profit | 4.03B |
| Operating Income | -6.09B |
| Pretax Income | -15.14B |
| Net Income | -12.91B |
| EBITDA | -5.52B |
| EBIT | -6.09B |
| Loss Per Share | -1,611.49 |
Balance Sheet
The company has 45.67 billion in cash and 18.36 billion in debt, with a net cash position of 27.31 billion or 3,410.58 per share.
| Cash & Cash Equivalents | 45.67B |
| Total Debt | 18.36B |
| Net Cash | 27.31B |
| Net Cash Per Share | 3,410.58 |
| Equity (Book Value) | 43.71B |
| Book Value Per Share | 5,443.19 |
| Working Capital | 20.98B |
Cash Flow
In the last 12 months, operating cash flow was -5.95 billion and capital expenditures -35.64 million, giving a free cash flow of -5.98 billion.
| Operating Cash Flow | -5.95B |
| Capital Expenditures | -35.64M |
| Depreciation & Amortization | 567.38M |
| Net Borrowing | -424.08M |
| Free Cash Flow | -5.98B |
| FCF Per Share | -747.12 |
Margins
Gross margin is 65.17%, with operating and profit margins of -98.54% and -208.94%.
| Gross Margin | 65.17% |
| Operating Margin | -98.54% |
| Pretax Margin | -245.00% |
| Profit Margin | -208.94% |
| EBITDA Margin | -89.36% |
| EBIT Margin | -98.54% |
| FCF Margin | n/a |
Dividends & Yields
TegoScience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.40% |
| Shareholder Yield | -0.40% |
| Earnings Yield | -21.28% |
| FCF Yield | -9.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 11, 2018. It was a forward split with a ratio of 2.
| Last Split Date | Jul 11, 2018 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
TegoScience has an Altman Z-Score of 2.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.21 |
| Piotroski F-Score | 2 |